SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-263453
Filing Date
2013-06-19
Accepted
2013-06-19 08:01:23
Documents
4
Period of Report
2013-06-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d556312d8k.htm 8-K 17185
2 EX-99.1 d556312dex991.htm EX-99.1 8511
3 GRAPHIC g556312img01.jpg GRAPHIC 14047
4 GRAPHIC g556312img02.jpg GRAPHIC 7923
  Complete submission text file 0001193125-13-263453.txt   57567
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 13920844
SIC: 2834 Pharmaceutical Preparations